🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/11/2010 | 58,86 | 60,07 | 58,73 | 59,91 | +0,86% | 2,28% | 662.800 |
| 10/11/2010 | 58,80 | 59,55 | 58,57 | 59,40 | +1,33% | 1,67% | 824.300 |
| 09/11/2010 | 59,08 | 59,50 | 58,52 | 58,62 | -0,95% | 1,66% | 392.100 |
| 08/11/2010 | 59,12 | 59,49 | 58,60 | 59,18 | -0,08% | 1,51% | 593.300 |
| 05/11/2010 | 59,59 | 59,66 | 58,54 | 59,23 | -0,39% | 1,88% | 495.700 |
| 04/11/2010 | 60,54 | 61,42 | 59,11 | 59,46 | -0,73% | 3,82% | 1.069.200 |
| 03/11/2010 | 59,90 | 60,25 | 59,14 | 59,90 | -0,17% | 1,85% | 802.900 |
| 02/11/2010 | 59,64 | 60,65 | 59,26 | 60,00 | -0,22% | 2,33% | 721.900 |
| 01/11/2010 | 60,54 | 60,72 | 59,72 | 60,13 | +0,22% | 1,65% | 1.042.900 |
| 29/10/2010 | 59,90 | 60,93 | 59,85 | 60,00 | +0,96% | 1,80% | 1.230.300 |
| 28/10/2010 | 57,83 | 60,00 | 57,83 | 59,43 | +6,98% | 3,75% | 2.969.300 |
| 27/10/2010 | 54,87 | 55,92 | 54,51 | 55,55 | +0,47% | 2,57% | 869.400 |
| 26/10/2010 | 55,33 | 55,68 | 54,87 | 55,29 | -0,32% | 1,46% | 489.400 |
| 25/10/2010 | 54,82 | 55,72 | 54,62 | 55,47 | +1,57% | 2,01% | 396.200 |
| 22/10/2010 | 54,46 | 54,81 | 54,32 | 54,61 | +0,61% | 0,90% | 215.800 |
| 21/10/2010 | 54,80 | 55,22 | 53,91 | 54,28 | -0,49% | 2,39% | 518.900 |
| 20/10/2010 | 54,24 | 55,19 | 53,76 | 54,55 | +0,53% | 2,64% | 529.300 |
| 19/10/2010 | 54,88 | 55,05 | 54,01 | 54,26 | -2,16% | 1,90% | 737.400 |
| 18/10/2010 | 55,65 | 55,83 | 55,33 | 55,46 | -0,02% | 0,90% | 347.800 |
| 15/10/2010 | 55,89 | 56,29 | 55,39 | 55,47 | -0,47% | 1,61% | 623.300 |
| 14/10/2010 | 55,83 | 56,37 | 55,56 | 55,73 | -0,23% | 1,45% | 630.000 |
| 13/10/2010 | 56,26 | 56,26 | 55,55 | 55,86 | -0,34% | 1,26% | 442.500 |
| 12/10/2010 | 55,64 | 56,18 | 55,19 | 56,05 | +0,66% | 1,78% | 503.700 |
| 11/10/2010 | 55,54 | 55,85 | 54,50 | 55,68 | -0,29% | 2,43% | 439.900 |
| 08/10/2010 | 55,55 | 56,00 | 55,46 | 55,84 | +0,76% | 0,97% | 550.600 |
| 07/10/2010 | 55,13 | 55,55 | 54,95 | 55,42 | +0,53% | 1,09% | 561.900 |
| 06/10/2010 | 56,75 | 57,13 | 53,98 | 55,13 | -3,14% | 5,55% | 1.634.900 |
| 05/10/2010 | 56,42 | 57,00 | 56,28 | 56,92 | +1,59% | 1,28% | 524.800 |
| 04/10/2010 | 56,54 | 57,14 | 55,73 | 56,03 | -0,88% | 2,49% | 481.600 |
| 01/10/2010 | 56,42 | 56,64 | 55,64 | 56,53 | +0,93% | 1,77% | 573.800 |